IL1B and Stroke: Inflammation is recognized as a major contributor to the worsening of acute brain injury and inhibiting IL-1 with the receptor antagonist (IL-1Ra) is protective in experimental models of stroke (Brough et al., 2011), and has shown promise as a treatment in clinical trials (Emsley et al., 2005).